Trial · NCT00968812
Adverse event totals18
The totals the trial posted for each group.
1 to 18 of 18
Download this page as JSON| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Canagliflozin 100 mg: Baseline to Week 52 | ||
| Total, all-cause mortality | Canagliflozin 300 mg: Baseline to Week 52 | ||
| Total, all-cause mortality | Glimepiride: Baseline to Week 52 | ||
| Total, all-cause mortality | Canagliflozin 100 mg: Baseline to Week 104 | ||
| Total, all-cause mortality | Canagliflozin 300 mg: Baseline to Week 104 | ||
| Total, all-cause mortality | Glimepiride: Baseline to Week 104 | ||
| Total, other adverse events | Canagliflozin 100 mg: Baseline to Week 52 | 138 | 483 |
| Total, other adverse events | Canagliflozin 300 mg: Baseline to Week 52 | 150 | 485 |
| Total, other adverse events | Glimepiride: Baseline to Week 52 | 175 | 482 |
| Total, other adverse events | Canagliflozin 100 mg: Baseline to Week 104 | 198 | 483 |
| Total, other adverse events | Canagliflozin 300 mg: Baseline to Week 104 | 204 | 485 |
| Total, other adverse events | Glimepiride: Baseline to Week 104 | 242 | 482 |
| Total, serious adverse events | Canagliflozin 100 mg: Baseline to Week 52 | 24 | 483 |
| Total, serious adverse events | Canagliflozin 300 mg: Baseline to Week 52 | 26 | 485 |
| Total, serious adverse events | Glimepiride: Baseline to Week 52 | 39 | 482 |
| Total, serious adverse events | Canagliflozin 100 mg: Baseline to Week 104 | 47 | 483 |
| Total, serious adverse events | Canagliflozin 300 mg: Baseline to Week 104 | 47 | 485 |
| Total, serious adverse events | Glimepiride: Baseline to Week 104 | 69 | 482 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00968812/event-totals